Clincosm LogoSign in Get a demo

mcrpc

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial (INKmune)

Not yet recruiting
  • Cancer
  • +2 more
  • INKmune
  • (no location specified)
Sep 27, 2023

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

Recruiting
  • Prostate Cancer
  • +5 more
  • 177Lu-rhPSMA-10.1 injection
  • 18F-rhPSMA-7.3 injection
  • Glen Burnie, Maryland
  • +3 more
Feb 2, 2023

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

Prostate Cancer, mCRPC Trial in Seoul (Lu-177-DGUL, Ga-68-NGUL)

Recruiting
  • Prostate Cancer
  • mCRPC
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2022

Prostate Cancer, mCRPC, mCSPC Trial in United States (PRL-02, Prednisone, dexamethasone)

Recruiting
  • Prostate Cancer
  • +2 more
  • Jeffersonville, Indiana
  • +7 more
Aug 17, 2022

mCRPC Trial in Worldwide (Talazoparib with enzalutamide, Placebo with enzalutamide)

Active, not recruiting
  • mCRPC
  • Talazoparib with enzalutamide
  • Placebo with enzalutamide
  • Anchorage, Alaska
  • +363 more
Aug 3, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Melbourne (Cabazitaxel, 177Lu-PSMA-617)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • mCRPC
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Jul 20, 2022

mCRPC Trial in San Francisco, Portland (ZEN003694, Enzalutamide)

Enrolling by invitation
  • mCRPC
  • San Francisco, California
  • +1 more
May 31, 2022

Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)

Completed
Has Results
  • Metastatic Castrate-resistant Prostate Cancer
  • mCRPC
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 11, 2022

mCRPC Trial in Australia, China, United States (Placebo, Senaparib)

Not yet recruiting
  • mCRPC
  • Binghamton, New York
  • +5 more
Dec 14, 2021

mCRPC Trial in Shanghai (HC-1119, )

Recruiting
  • mCRPC
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 26, 2021